Tri Locum Partners LP Vera Therapeutics, Inc. Transaction History
Tri Locum Partners LP
- $168 Million
- Q1 2025
A detailed history of Tri Locum Partners LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Tri Locum Partners LP holds 150,207 shares of VERA stock, worth $2.96 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
150,207Holding current value
$2.96 Million% of portfolio
2.15%Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
198Shares Held
63.7MCall Options Held
723KPut Options Held
193K-
Avoro Capital Advisors LLC New York, NY5.7MShares$112 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$93.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$65.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$58.4 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$57.6 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $533M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...